Lawrence Ham, PA
Physician Assistant · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · North East Medical Services · 143 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lawrence Ham’s office to ask if they take your plan before you enroll.
Medicaid work
$4,004 in 2024
Medicaid paid $4,004 for 765 billed services this clinician did in 2024, up to 54 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 445 | $2,094 |
| Return visit (30+ min) | 320 | $1,910 |
| 2024 | 765 | 2 | 54 | $4,004 |
| 2023 | 861 | 2 | 81 | $3,661 |
| 2022 | 124 | 2 | 43 | $356 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 611 | $2,569 |
| Short return visit (20+ min) | 250 | $1,091 |
2022
| Short return visit (20+ min) | 109 | $228 |
| Return visit (30+ min) | 15 | $128 |
Drugs they prescribed that Part D paid
$52,787
Pharmacies billed $52,787 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (11 of 704) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
619 generic and fewer than 11 brand-name prescriptions · $52,787 in drug cost · 15 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 21 | $716 | $34 |
| Levothyroxine | 30 | $211 | $7 |
| Atorvastatin | 68 | $199 | $3 |
| Metformin | 40 | $154 | $4 |
| Amlodipine Besylate | 44 | $136 | $3 |
See all 12 drugs
| Albuterol Sulfate Hfa | 21 | $716 | $34 |
| Levothyroxine | 30 | $211 | $7 |
| Atorvastatin | 68 | $199 | $3 |
| Metformin | 40 | $154 | $4 |
| Amlodipine Besylate | 44 | $136 | $3 |
| Omeprazole | 15 | $135 | $9 |
| Triamcinolone Acetonide | 12 | $115 | $10 |
| Losartan | 25 | $99 | $4 |
| Diclofenac | 14 | $90 | $6 |
| Hydrochlorothiazide | 28 | $52 | $2 |
| Lisinopril | 36 | $51 | $1 |
| Naproxen | 13 | $47 | $4 |
Year by year
| 2024 | 704 | 131 | 2% (11) | None | $52,787 |
| 2023 | 570 | 140 | None | None | $64,921 |
| 2022 | 46 | 22 | 0% (0) | None | $2,201 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Atorvastatin | 62 | $1,111 | $18 |
| Metformin | 36 | $570 | $16 |
| Amlodipine Besylate | 34 | $441 | $13 |
| Levothyroxine | 22 | $439 | $20 |
| Lisinopril | 28 | $421 | $15 |
| Tamsulosin | 12 | $384 | $32 |
| Gabapentin | 13 | $347 | $27 |
| Hydroxyzine | 11 | $325 | $30 |
| Albuterol Sulfate Hfa | 11 | $264 | $24 |
| Glipizide | 11 | $208 | $19 |
| Losartan | 12 | $198 | $16 |
| Hydrochlorothiazide | 15 | $181 | $12 |
| Triamcinolone Acetonide | 14 | $153 | $11 |
Money from drug and device companies
$454 in 2025
| 2025 | 4 | 4 | None | $454 |
| 2024 | 8 | 9 | None | $559 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Madrigal Pharmaceuticals | Rezdiffra | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | None | $112 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $109 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $108 | 1 payment
|
See all 4 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-10 | None | $112 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-19 | Fasenra | $108 |
| Janssen Pharmaceuticals | Meals · 2025-06-27 | Spravato | $109 |
| Madrigal Pharmaceuticals | Meals · 2025-04-17 | Rezdiffra | $125 |
See earlier years (2024)
2024: $559
| Gilead Sciences | Biktarvy | $153 | 2 payments
|
| Novo Nordisk | None | $114 | 1 payment
|
| Si-Bone | None | $112 | 1 payment
|
| Biogen | Spinraza | $93 | 1 payment
|
| Merck Sharp & Dohme | Gardasil | $25 | 1 payment
|
| Pfizer | Prevnar 20 | $22 | 1 payment
|
| Phadia US | Immunocap | $20 | 1 payment
|
| Organon | Nexplanon | $19 | 1 payment
|
Professional record
- NPI
- 1235806621
- Licence
- CA 61234
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- Po Box 2092, Castro Valley, CA, 94546
- NPI first listed
- 2021-08-24
- NPI last updated
- 2025-01-12
- NPI record certified
- 2025-01-09
This is when the NPI record was last certified, not a medical board exam.